That ICS should be First Line Therapy for Asthma – Con

Publication year: 2011 Source: Paediatric Respiratory Reviews, Available online 17 September 2011 Peter Paul van Asperen Asthma is a heterogeneous disease and it is therefore unrealistic to expect that inhaled corticosteroids (ICS) would be appropriate first line preventer therapy for all children with asthma. There is good theoretical and clinical trial evidence demonstrating that leukotriene receptor antagonists (LTRAs) are more effective than ICS for viral induced wheezing and equivalent to ICS for mild persistent asthma in children.

Publication year: 2011 Source: Paediatric Respiratory Reviews, Available online 17 September 2011 Peter Paul van Asperen Asthma is a heterogeneous disease and it is therefore unrealistic to expect that inhaled corticosteroids (ICS) would be appropriate first line preventer therapy for all children with asthma. There is good theoretical and clinical trial evidence demonstrating that leukotriene receptor antagonists (LTRAs) are more effective than ICS for viral induced wheezing and equivalent to ICS for mild persistent asthma in children.

See the original post:
That ICS should be First Line Therapy for Asthma – Con